PG — The Procter & Gamble Company $146.64

Generated 2026-06-30 21:50

Quality Scorecard Stable

A86/100
Pricing power (gross margin) 51% Gross margin 51% — wide margins, likely pricing power
Return on equity 31% ROE 31% — high returns on capital
Leverage (net debt / EBITDA) 1.0x Net debt / EBITDA 1.0x — low leverage
Interest coverage 23x EBIT covers interest 23x — comfortably covered
Earnings consistency (revenue) 0/3 down 0 revenue-down year(s) in 3 — no down years
🟡 Earnings growth (net income YoY) +7% Net income +7% YoY — earnings roughly flat
Cash conversion (CFO/NI) 112% Operating cash ÷ net income 112% — earnings convert to cash
Operating margin trend eroding Operating margin eroding
Free cash flow margin 17% FCF margin 17% — strong cash generation
Returns capital to shareholders yes dividend ~2.9%; shares -1.1%/yr
Buyback efficiency (net share-count Δ) -1.1%/yr Shares outstanding -1.1% YoY — share count shrinking

Stable-stage checklist (proxy metrics from yfinance). 11 of 11 criteria scored. Not financial advice.

Buy-Now Score

61/100
Quality ×40%86
Trajectory ×30%33
Valuation ×30%54

Comparative rank: 40% Quality + 30% Trajectory + 30% Valuation — higher = better buy now. Not financial advice.

Valuation

$99.20$179.92
Price $146.64DCF $110.22 (-25%)Analyst $163.57 (+12%)MarketGist fair $152.90 (+4%)

DCF: 0% start growth → 2.5%, 7.0% discount (band $96.16–$133.98). Analyst: 23 analysts. MarketGist fair = 80% analyst + 20% DCF. Not financial advice.

Key Trends (6-yr)

GAAP EPS
▲ +8.1% YoY
Sales
▲ +0.3% YoY
Shares Outstanding
▼ -0.7% YoY

Company Overview

Basic Information

Company Name: The Procter & Gamble Company
Symbol: PG
Exchange: NYQ
Sector: Consumer Defensive
Industry: Household & Personal Products

Company Details

Country: United States
City: Cincinnati
Employees: 109,000
Market Cap: $341.47B

Business Description

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Key Metrics

Price & Valuation

Current Price
$146.64
Market Cap
$341.47B
P/E Ratio
21.44
Forward P/E
20.70
PEG Ratio
4.19
Price to Book
6.35

Profitability

Profit Margin: 19.16%
Operating Margin: 23.05%
Gross Margin: 50.98%
Return on Equity (ROE): 31.11%
Return on Assets (ROA): 10.93%
Revenue Growth: 7.40%

Financial Health

Current Ratio: 0.73
Quick Ratio: 0.49
Debt to Equity: 67.65
Total Debt: $37.03B
Total Cash: $12.31B
Beta: 0.39

Trading & Analyst Info

52-Week Range

52-Week High: $167.25
52-Week Low: $137.62
50-Day Average: $145.90
200-Day Average: $148.68

Analyst Recommendations

Recommendation: BUY
Target Mean Price: $163.57
Target High: $186.00
Target Low: $145.00

Price graph

Price vs Rates, Inflation & Volume (long-term)

Dotted = market-implied expectation (next ~12 mo), not a prediction.

Quarterly Verdict

🟢 96/100

Worth buying

Quality grade A; 4 improving / 2 weakening metrics YoY.

➕ Pricing power (gross margin): Gross margin 51% — wide margins, likely pricing power
➕ Return on equity: ROE 31% — high returns on capital
➕ Leverage (net debt / EBITDA): Net debt / EBITDA 1.0x — low leverage
➕ Interest coverage: EBIT covers interest 23x — comfortably covered
➕ Earnings consistency (revenue): 0 revenue-down year(s) in 3 — no down years
➕ Cash conversion (CFO/NI): Operating cash ÷ net income 112% — earnings convert to cash
➖ Operating margin trend: Operating margin eroding
➕ Free cash flow margin: FCF margin 17% — strong cash generation
➕ Returns capital to shareholders: dividend ~2.9%; shares -1.1%/yr
➕ Buyback efficiency (net share-count Δ): Shares outstanding -1.1% YoY — share count shrinking
➕ Revenue +7.4% YoY
➕ Net income +4.3% YoY
➖ Operating margin -1.5 pts YoY
➕ Free cash flow +6.3% YoY
➕ Cash +35.0% YoY
➖ Debt +8.5% YoY

Heuristic from the Quality Scorecard + quarter-over-quarter trends. Not financial advice.

Financial Statements

Income Statement (Annual)

Item2025-06-302024-06-302023-06-302022-06-30
Tax Effect Of Unusual Items$0.00$-270.88M$0.00$0.00
Tax Rate For Calcs$0.20$0.20$0.02$0.18
Normalized EBITDA$23.92B$23.92B$21.82B$21.24B
Total Unusual Items$0.00$-1.34B$0.00$0.00
Total Unusual Items Excluding Goodwill$0.00$-1.34B$0.00$0.00
Net Income From Continuing Operation Net Minority Interest$15.97B$14.88B$14.65B$14.74B
Reconciled Depreciation$2.85B$2.90B$2.71B$2.81B
Reconciled Cost Of Revenue$41.16B$40.85B$42.76B$42.16B
EBITDA$23.92B$22.58B$21.82B$21.24B
EBIT$21.07B$19.69B$19.11B$18.43B
Net Interest Income$-438.00M$-452.00M$-449.00M$-388.00M
Interest Expense$907.00M$925.00M$756.00M$439.00M
Interest Income$469.00M$473.00M$307.00M$51.00M
Normalized Income$15.97B$15.95B$14.65B$14.74B
Net Income From Continuing And Discontinued Operation$15.97B$14.88B$14.65B$14.74B

Showing 15 of 45 rows

Balance Sheet (Annual)

Item2025-06-302024-06-302023-06-302022-06-30
Treasury Shares Number$1.67B$1.65B$1.65B$1.62B
Ordinary Shares Number$2.34B$2.36B$2.36B$2.39B
Share Issued$4.01B$4.01B$4.01B$4.01B
Net Debt$24.95B$22.98B$26.36B$24.28B
Total Debt$35.46B$33.37B$35.42B$32.29B
Tangible Book Value$-12.32B$-12.86B$-18.48B$-17.63B
Invested Capital$85.74B$81.95B$80.56B$77.24B
Working Capital$-10.67B$-8.92B$-13.11B$-11.43B
Net Tangible Assets$-11.55B$-12.06B$-17.66B$-16.79B
Capital Lease Obligations$956.00M$909.00M$817.00M$800.00M
Common Stock Equity$51.23B$49.49B$45.96B$45.75B
Preferred Stock Equity$777.00M$798.00M$819.00M$843.00M
Total Capitalization$77.01B$75.56B$71.16B$69.44B
Total Equity Gross Minority Interest$52.28B$50.56B$47.06B$46.85B
Minority Interest$272.00M$272.00M$288.00M$265.00M

Showing 15 of 80 rows

Cash Flow Statement (Annual)

Item2025-06-302024-06-302023-06-302022-06-30
Free Cash Flow$14.04B$16.52B$13.79B$13.57B
Repurchase Of Capital Stock$-6.50B$-5.01B$-7.35B$-10.00B
Repayment Of Debt$-9.63B$-10.02B$-18.23B$-13.82B
Issuance Of Debt$10.26B$7.58B$21.16B$15.71B
Capital Expenditure$-3.77B$-3.32B$-3.06B$-3.16B
Interest Paid Supplemental Data$896.00M$878.00M$721.00M$451.00M
Income Tax Paid Supplemental Data$4.55B$4.36B$4.28B$3.82B
End Cash Position$9.56B$9.48B$8.25B$7.21B
Beginning Cash Position$9.48B$8.25B$7.21B$10.29B
Effect Of Exchange Rate Changes$112.00M$-251.00M$-170.00M$-497.00M
Changes In Cash$-38.00M$1.49B$1.20B$-2.58B
Financing Cash Flow$-14.04B$-14.86B$-12.15B$-14.88B
Cash Flow From Continuing Financing Activities$-14.04B$-14.86B$-12.15B$-14.88B
Net Other Financing Charges$-1.00MN/AN/AN/A
Proceeds From Stock Option Exercised$1.71B$1.91B$1.27B$2.00B

Showing 15 of 53 rows

Data via yfinance. Prices may be delayed. · Privacy

Disclaimer: MarketGist is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice, nor a recommendation, offer, or solicitation to buy or sell any security. Data is sourced automatically (e.g. via yfinance and other third parties) and may be delayed, inaccurate, or incomplete. Investing involves risk, including the possible loss of principal; past performance does not guarantee future results. MarketGist is not a registered investment adviser or broker-dealer. Always do your own research and consult a licensed financial professional before making any investment decision. By using this site you agree that MarketGist and its authors accept no liability for any loss or damage arising from reliance on its content.